Thursday - April 09, 2026

Category Archives: Marketing & Sales

3G Shielding Specialties Explains Why Use Custom PCB Shielding Suppliers for High-Performance Electronics

As electronic devices become increasingly compact and powerful, manufacturers are facing growing challenges related to electromagnetic interference (EMI) at the circuit board level. In response to this trend, 3G Shielding Specialties has shared insights into why using custom PCB shielding … Continue reading →

3G Shielding Specialties Shares Insights on “Best Board Level EMI Shielding Options” for Modern Devices

As electronic devices continue to become smaller, faster, and more complex, the need for effective board level EMI shielding options has become a top priority for engineers and manufacturers across industries. Addressing this growing challenge, 3G Shielding Specialties has shared … Continue reading →

MG Makeovers Cements Its Position as Gurgaon’s #1 Rated Beauty Studio, Offering Everything from Nail Extensions and Eyelash Lifts to Permanent Makeup

GURGAON, India – MG Makeovers, founded by award-winning makeup artist Madhu Gupta, has established itself as Gurgaon’s most trusted full-service beauty studio and clinic — a single destination where clients can access professional-grade makeup, nails, lashes, skin, hair, permanent makeup (PMU), … Continue reading →

Shengzhong Shredder Announces Strategic Advancements in Industrial Shredder Technology to Support Global Buyers’ Procurement Demands in 2026

Maanshan Shengzhong Heavy Industrial Machinery Co., Ltd. Shengzhong Shredder announces expanded Industrial Shredder solutions for global buyers, highlighting new high‑torque systems, faster production, and enhanced QC. With strong R&D, ISO‑based manufacturing, and proven case projects worldwide, the company delivers reliable … Continue reading →

Multiple System Atrophy Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Neuramedy, ProMIS Neurosciences, Enterin Inc., Nippon Chemiphar

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Multiple System Atrophy pipeline constitutes 20+ key companies continuously working towards developing 22+ Multiple System Atrophy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading →

TECHSPO Dubai 2026 Unites Business, Tech and Marketing Leaders for High-Impact Expo

Dubai, UAE – TECHSPO Dubai Technology Expo returns September 22-23, 2026, to the Sofitel Dubai Jumeirah Beach Hotel, uniting business leaders, technologists, marketers, and innovators for a high-impact, two-day showcase of next-generation digital technology. Part of the globally recognized TECHSPO … Continue reading →

DigiMarCon Silicon Valley 2026 Returns to San Francisco, Bringing the Future of Digital Marketing to the Global Stage

San Francisco, CA – DigiMarCon Silicon Valley, the premier digital marketing, media, advertising, and business conference and exhibition in the CA, will return June 16-17, 2026, at the Grand Hyatt San Francisco Hotel in San Francisco, CA. The three-day event … Continue reading →

Non Tuberculous Mycobacterial Infections Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Insmed, AN2 Therapeutics, Mannkind Corp., Spero Therapeutics, Savara Pharmaceuticals

The Key Non- Tuberculous Mycobacterial Infections Companies in the market include – Insmed, AN2 Therapeutics, Mannkind Corporation, Spero Therapeutics, Savara Pharmaceuticals, Mallinckrodt Inc., Paratek Pharmaceuticals Inc., Revimmune, and others .   The Non- Tuberculous Mycobacterial Infections market is expected to … Continue reading →

Hypertrophic Cardiomyopathy Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Tenaya Therapeutics, Shandong Suncadia Medicine, MyoKardia

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Hypertrophic Cardiomyopathy pipeline constitutes 10+ key companies continuously working towards developing 10+ Hypertrophic Cardiomyopathy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading →